What is a stock summary page? Click here for an overview.
Business Description
Anuh Pharma Ltd
ISIN : INE489G01022
Share Class Description:
BOM:506260: Shs DematerialisedCompare
Compare
Traded in other countries / regions
506260.India IPO Date
1993-08-18Description
Anuh Pharma Ltd is engaged in the business of manufacturing and selling of Bulk drugs and chemicals. Geographically, it derives a majority of revenue from India. Its product categories include macrolides, anti-TB, anti-malarial, anti-bacterial, anti-hypertension, expectorant, quinolones, and others. The company generates revenue from the sale of Branded Prescription drugs, Over-the-Counter (OTC) drugs and Generic Prescription drugs.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 3.7 | |||||
| Equity-to-Asset | 0.7 | |||||
| Debt-to-Equity | 0.05 | |||||
| Debt-to-EBITDA | 0.2 | |||||
| Interest Coverage | 79.11 | |||||
| Piotroski F-Score | 8/9 | |||||
| Altman Z-Score | 6.38 | |||||
| Beneish M-Score | -1.76 | |||||
| WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 14.4 | |||||
| 3-Year EBITDA Growth Rate | 16.5 | |||||
| 3-Year EPS without NRI Growth Rate | 31.6 | |||||
| 3-Year Book Growth Rate | 15.2 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 48.71 | |||||
| 9-Day RSI | 53.05 | |||||
| 14-Day RSI | 53.28 | |||||
| 3-1 Month Momentum % | -22.74 | |||||
| 6-1 Month Momentum % | -16.48 | |||||
| 12-1 Month Momentum % | -37.76 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.43 | |||||
| Quick Ratio | 1.88 | |||||
| Cash Ratio | 0.4 | |||||
| Days Inventory | 57.62 | |||||
| Days Sales Outstanding | 101.67 | |||||
| Days Payable | 93.95 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.37 | |||||
| Dividend Payout Ratio | 0.3 | |||||
| Forward Dividend Yield % | 1.37 | |||||
| 5-Year Yield-on-Cost % | 1.37 | |||||
| Shareholder Yield % | 1.01 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 24.82 | |||||
| Operating Margin % | 8.67 | |||||
| Net Margin % | 8.01 | |||||
| FCF Margin % | 1.26 | |||||
| ROE % | 17.71 | |||||
| ROA % | 11.78 | |||||
| ROIC % | 17.51 | |||||
| 3-Year ROIIC % | 70.01 | |||||
| ROC (Joel Greenblatt) % | 37.02 | |||||
| ROCE % | 22.46 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 17.22 | |||||
| PE Ratio without NRI | 20.59 | |||||
| Shiller PE Ratio | 23.93 | |||||
| Price-to-Owner-Earnings | 57.07 | |||||
| PEG Ratio | 0.95 | |||||
| PS Ratio | 1.38 | |||||
| PB Ratio | 2.85 | |||||
| Price-to-Tangible-Book | 2.86 | |||||
| Price-to-Free-Cash-Flow | 109.41 | |||||
| Price-to-Operating-Cash-Flow | 66.95 | |||||
| EV-to-EBIT | 12.91 | |||||
| EV-to-EBITDA | 11.44 | |||||
| EV-to-Revenue | 1.32 | |||||
| EV-to-FCF | 103.88 | |||||
| Price-to-GF-Value | 1.16 | |||||
| Price-to-Projected-FCF | 2.57 | |||||
| Price-to-Median-PS-Value | 0.9 | |||||
| Price-to-Peter-Lynch-Fair-Value | 1.07 | |||||
| Price-to-Graham-Number | 1.47 | |||||
| Price-to-Net-Current-Asset-Value | 4.72 | |||||
| Earnings Yield (Greenblatt) % | 7.76 | |||||
| FCF Yield % | 0.92 | |||||
| Forward Rate of Return (Yacktman) % | 19.33 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Anuh Pharma Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 6,272.661 | ||
| EPS (TTM) (₹) | 10.02 | ||
| Beta | 0.76 | ||
| 3-Year Sharpe Ratio | 0.48 | ||
| 3-Year Sortino Ratio | 0.83 | ||
| Volatility % | 41.84 | ||
| 14-Day RSI | 53.28 | ||
| 14-Day ATR (₹) | 7.974549 | ||
| 20-Day SMA (₹) | 167.385 | ||
| 12-1 Month Momentum % | -37.76 | ||
| 52-Week Range (₹) | 148.05 - 261 | ||
| Shares Outstanding (Mil) | 50.11 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 8 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Anuh Pharma Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Anuh Pharma Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Anuh Pharma Ltd Frequently Asked Questions
What is Anuh Pharma Ltd(BOM:506260)'s stock price today?
The current price of BOM:506260 is ₹172.75. The 52 week high of BOM:506260 is ₹261.00 and 52 week low is ₹148.05.
When is next earnings date of Anuh Pharma Ltd(BOM:506260)?
The next earnings date of Anuh Pharma Ltd(BOM:506260) is .
Does Anuh Pharma Ltd(BOM:506260) pay dividends? If so, how much?
The Dividend Yield %  of Anuh Pharma Ltd(BOM:506260) is 1.37% (As of Today), Highest Dividend Payout Ratio of Anuh Pharma Ltd(BOM:506260) was 0.85. The lowest was 0.07. And the median was 0.31. The  Forward Dividend Yield % of Anuh Pharma Ltd(BOM:506260) is 1.37%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers